Factors for Assessing Employment-Based Risks of Participation in Psychedelic Research
Rachel J. Topazian, Michael J. DiStefano, Gianna Morales, Matthew DeCamp
The American Journal of Bioethics September 18, 2026 DOI: 10.1080/15265161.2026.2717100 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|
Abstract
The case raises questions regarding what constitutes employment-based risks in psychedelic research, with specific focus on workplace drug testing policies, and whether these risks merit additional...
Citations in the library
Cites 3
- Essentials of Informed Consent to Psychedelic Medicine JAMA Psychiatry April 10, 2024
- Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement. JAMA Network Open June 3, 2024
- Employment-Related Risks in a Clinical Trial of Psychedelic Treatment for Chronic Pain The American Journal of Bioethics September 18, 2026